Mathew Coleman

Dr.

Accepting PhD Students

PhD projects

Mathew Coleman's research focusses on the role of protein hydroxylation in the cell biology of tumour cells. He has attracted highly competitive funding support from Cancer Research UK, the MRC, BBSRC and Glaxo Smith Kline. His work on protein hydroxylation has led to patents, and highly cited articles and high impact research and review publications including most recently in Nature, Nature Chemical Biology, PNAS and Molecular Cell. The Tumour Oxygenase Group always welcomes applications from talented and enthusiastic doctoral researchers to study the role of protein hydroxylation in cancer.

20012021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

University of Oxford

External organisation: University or other Higher Education Institute

King Abdulaziz University

External organisation: University or other Higher Education Institute

Friedrich-Alexander University Erlangen-Nuremberg

External organisation: University or other Higher Education Institute

Newcastle University

External organisation: University or other Higher Education Institute

Jikei University School of Medicine

External organisation: University or other Higher Education Institute

Universitätsklinikum Erlangen

External organisation: University or other Higher Education Institute

Hokkaido University

External organisation: University or other Higher Education Institute

University of Rome La Sapienza

External organisation: University or other Higher Education Institute

TES Pharma S.r.l.

External organisation: Unknown

Leloir Institute Foundation

External organisation: No HESA Fund Source

University of Birmingham

External organisation: University or other Higher Education Institute

Chiba University

External organisation: Unknown